首页> 美国卫生研究院文献>Cancer Communications >Boron neutron capture therapy: Current status and future perspectives
【2h】

Boron neutron capture therapy: Current status and future perspectives

机译:硼中子捕获治疗:当前状态和未来的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of new accelerators has given a new impetus to the development of new drugs and treatment technologies using boron neutron capture therapy (BNCT). We analyzed the current status and future directions of BNCT for cancer treatment, as well as the main issues related to its introduction. This review highlights the principles of BNCT and the key milestones in its development: new boron delivery drugs and different types of charged particle accelerators are described; several important aspects of BNCT implementation are discussed. BCNT could be used alone or in combination with chemotherapy and radiotherapy, and it is evaluated in light of the outlined issues. For the speedy implementation of BCNT in medical practice, it is necessary to develop more selective boron delivery agents and to generate an epithermal neutron beam with definite characteristics. Pharmacological companies and research laboratories should have access to accelerators for large‐scale screening of new, more specific boron delivery agents.
机译:新加速器的发展为使用硼中子捕获疗法(BNCT)开发了新的药物和治疗技术的新推动力。我们分析了BNCT对癌症治疗的现状和未来方向,以及与其介绍相关的主要问题。本综述突出了BNCT的原则和其开发中的主要里程碑:描述了新的硼递送药物和不同类型的带电粒子促进剂;讨论了BNCT实现的几个重要方面。 BCNT可以单独使用或与化疗和放射疗法组合使用,并根据概述的问题进行评估。为了快速实施BCNT在医疗实践中,有必要开发更多的选择性硼递送剂并产生具有明确特性的曲线中子束。药理公司和研究实验室应该可以获得加速器,用于大规模筛选新的,更具体的硼递送剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号